The principal investigators for the Smart Well Plate™ are Dr. Aaron Wheeler, Associate Professor of Chemistry at the University of Toronto, and internationally recognized analytical chemist and renowned cancer expert Dr. Jeff Wrana, Senior Investigator at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, Toronto.
"Ontario is proud to be home to world-class researchers like Dr. Aaron Wheeler and Dr. Jeff Wrana," said Glen Murray, Ontario's Minister of Research and Innovation. "Along with supporting the pursuit of new and better cancer treatments, the province's investments in OICR are helping promote R&D commercialization, capitalizing on opportunities to develop new technologies and create jobs."
OICR's investment is administered through the Intellectual Property Development and Commercialization Program, which provides seed funding for late stage academic projects that meet specific market-oriented criteria.
OICR will work closely with MaRS Innovation, the lead commercialization agent for this technology and the Innovations & Partnerships Office of the University of Toronto to support effective commercialization.
OICR, based in Ontario, Canada, is an innovative cancer research and development institute dedicated to prevention, early detection, diagnosis and treatment of cancer. The Institute is an independent, not-for-profit corporation funded by the Government of Ontario through the Ministry of Research and Innovation. OICR has 500 scientific staff (located at its headquarters and in research institutes and academia across the Province of Ontario) and an $85 million annual ope
|SOURCE The Ontario Institute for Cancer Research|
Copyright©2010 PR Newswire.
All rights reserved